SSOD39 - Ameloblastoma From A to Z

Ameloblastoma is the most common benign aggressive jaw tumor encountered by the maxillofacial surgeon. The behavior of this tumor is different in the maxilla and mandible. The treatment has evolved over the years, as has the reconstruction of the acquired defect. The course will illustrate the difference in behavior of the maxillary vs. mandibular ameloblastomas and the approaches to management. The course also will highlight the approach to reconstruction of small vs. large acquired defect after resection. Focus will be given on how to manage the recurrent lesion, those at the skull base and those in patient who are not medically fit for resection. Discussion also will include the malignant variant and the role of radiation therapy in treatment as well as targeted gene therapy in management of these jaw tumors.